Scarica l'app Stockscreener
45.11
1.16%
-0.53
Dopo l'orario di chiusura:
45.11
Precedente Chiudi:
$45.64
Aprire:
$46.08
Volume 24 ore:
669.58K
Relative Volume:
0.77
Capitalizzazione di mercato:
$3.57B
Reddito:
$399.58M
Utile/perdita netta:
$-54.04M
Rapporto P/E:
-60.15
EPS:
-0.75
Flusso di cassa netto:
$40.13M
1 W Prestazione:
+7.15%
1M Prestazione:
+1.12%
6M Prestazione:
+71.26%
1 anno Prestazione:
+6.17%
Intervallo 1D:
$44.97
$46.76
Intervallo di 1 settimana:
$41.48
$46.76
Portata 52W:
$22.61
$50.71
Veracyte Inc Stock (VCYT) Company Profile
Nome
Veracyte Inc
Settore
Industria
Telefono
(650) 243-6300
Indirizzo
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Confronta VCYT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
45.11 | 3.61B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
617.15 | 233.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.57 | 167.12B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.55 | 56.44B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.81 | 41.84B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
244.29 | 40.96B | 15.90B | 1.28B | 2.21B | 7.2842 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Underweight |
| 2025-10-20 | Iniziato | Canaccord Genuity | Hold |
| 2025-03-20 | Iniziato | Craig Hallum | Buy |
| 2024-12-05 | Downgrade | Goldman | Buy → Neutral |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-10-16 | Iniziato | UBS | Buy |
| 2024-10-10 | Iniziato | Guggenheim | Buy |
| 2024-02-23 | Reiterato | Needham | Buy |
| 2023-01-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-01-07 | Iniziato | Stephens | Overweight |
| 2021-11-18 | Ripresa | Goldman | Buy |
| 2021-06-15 | Iniziato | Raymond James | Outperform |
| 2021-02-18 | Ripresa | Needham | Buy |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Iniziato | Morgan Stanley | Underweight |
| 2019-07-31 | Iniziato | Lake Street | Buy |
| 2019-07-02 | Iniziato | Needham | Buy |
| 2018-11-29 | Downgrade | Janney | Buy → Neutral |
| 2018-10-31 | Aggiornamento | Janney | Neutral → Buy |
| 2017-11-07 | Downgrade | Janney | Buy → Neutral |
| 2017-11-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Ripresa | BTIG Research | Buy |
| 2016-11-14 | Ripresa | Leerink Partners | Outperform |
| 2015-12-18 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-06-11 | Reiterato | Leerink Partners | Outperform |
| 2013-11-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Veracyte Inc Borsa (VCYT) Ultime notizie
Here's Why You Should Retain Masimo Stock in Your Portfolio Now - Finviz
Guggenheim Raises Price Target for Veracyte (VCYT) to $50.00 | V - GuruFocus
Veracyte price target raised to $50 from $45 at Guggenheim - TipRanks
Morgan Stanley initiates coverage of Veracyte, Inc. (VCYT) - MSN
Veracyte (VCYT): Assessing Whether Recent Momentum Justifies Its Current Valuation - Yahoo Finance
The Truth About Veracyte Inc (VCYT): Silent Biotech Stock That Could Blow Up Your Portfolio - AD HOC NEWS
Yousif Capital Management LLC Takes Position in Veracyte, Inc. $VCYT - MarketBeat
Investment Review: How interest rate cuts could boost Veracyte Inc stock2025 Trade Ideas & Safe Entry Zone Tips - moha.gov.vn
Smart Oncology: 5 Stocks Chasing the $317B Prize - Cantech Letter
Morgan Stanley Initiates Coverage Of Veracyte, Inc. (VCYT) - Yahoo Finance
Zacks Industry Outlook Highlights Veracyte, IDEXX Laboratories and Intuitive Surgical - sharewise.com
Is This the Right Time to Add Veracyte Stock to Your Portfolio? - Eastern Progress
Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference - 01net
3 Medical Instrument Stocks to Counter Industry Woes Using GenAI - sharewise.com
12 Best Genomics Stocks to Invest In - Insider Monkey
Veracyte (NASDAQ:VCYT) Raised to Strong-Buy at Wall Street Zen - MarketBeat
Is this the right time to add Veracyte stock to your portfolio? - MSN
Veracyte, Inc. $VCYT Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Published on: 2025-12-25 21:43:38 - moha.gov.vn
What analysts say about Veracyte Inc stockFundamental Stock Analysis & Crush the Market with Breakout Winners - earlytimes.in
Veracyte Earnings Notes - Trefis
Why Veracyte Inc. (12V) stock remains top rated2025 Pullback Review & High Accuracy Swing Trade Signals - Улправда
How Veracyte Inc. stock benefits from global expansion2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - Улправда
How analysts rate Veracyte Inc. stock todayCPI Data & Safe Swing Trade Setup Alerts - Улправда
Layoff Watch: Is Veracyte Inc. stock a top pick in earnings seasonTrade Performance Summary & Daily Profit Focused Stock Screening - Улправда
Is Veracyte Inc. stock a top pick in earnings season2025 Price Momentum & Trade Opportunity Analysis - Улправда
Why Veracyte Inc. stock could outperform in 20252025 Volume Leaders & Free Expert Approved Momentum Trade Ideas - DonanımHaber
Will Veracyte Inc. stock gain from lower inflationMarket Performance Recap & Technical Confirmation Alerts - Bölüm Sonu Canavarı
What analyst consensus says on Veracyte Inc. stockWeekly Gains Summary & Smart Swing Trading Alerts - DonanımHaber
Fed Meeting: Why Veracyte Inc. stock could outperform in 2025Short Setup & Target Return Focused Stock Picks - DonanımHaber
Will Veracyte Inc. stock attract more institutional investorsWeekly Stock Summary & Low Drawdown Momentum Ideas - Улправда
Can Veracyte Inc. stock weather global recessionMarket Growth Summary & Low Risk Profit Maximizing Plans - Улправда
Can Veracyte Inc. stock deliver strong Q4 earningsIPO Watch & Detailed Earnings Play Strategies - Улправда
CEO Change: Is Veracyte Inc. stock a top pick in earnings seasonDividend Hike & Accurate Trade Setup Notifications - Улправда
Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 30% Discount? - Yahoo Finance
Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte (NASDAQ:VCYT) SVP Sells $463,173.07 in Stock - MarketBeat
Veracyte Executive Sells Shares Under Pre-arranged Trading Plan - TradingView — Track All Markets
Veracyte (VCYT) SVP & General Counsel reports insider stock sale - Stock Titan
Veracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Veracyte, Inc. $VCYT Shares Sold by Nikko Asset Management Americas Inc. - MarketBeat
Craig-Hallum Initiates Coverage of Veracyte (VCYT) with Buy Recommendation - MSN
Veracyte (NASDAQ:VCYT) Stock Rating Lowered by Wall Street Zen - MarketBeat
Morgan Stanley Maintains Veracyte (VCYT) Underweight Recommendation - MSN
First Trust Advisors LP Raises Holdings in Veracyte, Inc. $VCYT - MarketBeat
PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor - sharewise.com
Next Century Growth Investors LLC Lowers Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
JPMorgan Chase & Co. Buys 243,111 Shares of Veracyte, Inc. $VCYT - MarketBeat
Arrowstreet Capital Limited Partnership Sells 165,322 Shares of Veracyte, Inc. $VCYT - MarketBeat
Eastham (Veracyte director) sells $908k in VCYT stock By Investing.com - Investing.com Canada
Veracyte Inc Azioni (VCYT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.56%
2.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):